We found that UA inhibited proliferation of various human pancreatic cancer cells and potentiated the antitumor activity of gemcitabine through the inhibition of transcription factors NF-κB and STAT3 as well as multiple inflammatory gene products regulated by NF-κB and STAT3. The gene discussed is NFKB1; the disease is pancreatic neoplasm.